In order to determine the effectiveness of the grouping strategy between the low- and high-expression groups of CYB561 and FOLH1, the ESTIMATE method was applied to evaluate Tumor Purity, ESTIMATE Score, Immune Score, and Stromal Score. Here, FOLH1 is linked to neoplasm.